The FDA approved use of the 9vHPV vaccine for males aged 16-26 years, extending the previous indication that was for females aged 9-26 years and males aged 9-15 years. The current Advisory Committee on Immunization Practices’ (ACIP) 9vHPV vaccination recommendation includes males through age 21 and through age 26 years for men who have sex with […]

Go to Original Post